Document is current

Any future updates will be listed below

Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma

Crossref DOI link: https://doi.org/10.1007/s00277-014-2269-8

Published Online: 2015-01-30

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark